HIV injectable drug for Zimbabwe
Bringing you the best
Stay updated with breaking news from Tb Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country.The d...
ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country. The drug, an ARV designed to suppress any infection as it occurs, is for HIV-negative people who have a high risk of becoming infected with HIV. It is the third pre-exposure prophylaxis (PrEP) product…
“Each day, over 4,100 people lose their lives to TB, and close to 28,000 people fall ill with this preventable and curable disease.
77 Cases Reported In 2023, Up From 68 On 2022